505 related articles for article (PubMed ID: 25407397)
1. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
[TBL] [Abstract][Full Text] [Related]
3. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
8. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
Xu Z; Sandler DP; Taylor JA
J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
[TBL] [Abstract][Full Text] [Related]
9. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
Fraszczyk E; Spijkerman AMW; Zhang Y; Brandmaier S; Day FR; Zhou L; Wackers P; Dollé MET; Bloks VW; Gào X; Gieger C; Kooner J; Kriebel J; Picavet HSJ; Rathmann W; Schöttker B; Loh M; Verschuren WMM; van Vliet-Ostaptchouk JV; Wareham NJ; Chambers JC; Ong KK; Grallert H; Brenner H; Luijten M; Snieder H
Diabetologia; 2022 May; 65(5):763-776. PubMed ID: 35169870
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case-control Study.
Chamberlain JA; Dugué PA; Bassett JK; Milne RL; Joo JE; Wong EM; Brinkman MT; Stuart GW; Boussioutas A; Southey MC; Giles GG; Mitchell H; English DR; Hodge AM
Cancer Prev Res (Phila); 2021 Feb; 14(2):233-240. PubMed ID: 32958588
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.
Dugué PA; Brinkman MT; Milne RL; Wong EM; FitzGerald LM; Bassett JK; Joo JE; Jung CH; Makalic E; Schmidt DF; Park DJ; Chung J; Ta AD; Bolton DM; Lonie A; Longano A; Hopper JL; Severi G; Saffery R; English DR; Southey MC; Giles GG
Br J Cancer; 2016 Sep; 115(6):664-73. PubMed ID: 27490804
[TBL] [Abstract][Full Text] [Related]
12. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis.
van Veldhoven K; Polidoro S; Baglietto L; Severi G; Sacerdote C; Panico S; Mattiello A; Palli D; Masala G; Krogh V; Agnoli C; Tumino R; Frasca G; Flower K; Curry E; Orr N; Tomczyk K; Jones ME; Ashworth A; Swerdlow A; Chadeau-Hyam M; Lund E; Garcia-Closas M; Sandanger TM; Flanagan JM; Vineis P
Clin Epigenetics; 2015; 7(1):67. PubMed ID: 26244061
[TBL] [Abstract][Full Text] [Related]
13. [Detection of free tumor-related DNA in the serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Deng GR
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
15. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
[TBL] [Abstract][Full Text] [Related]
18. Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood.
Huang YT; Chu S; Loucks EB; Lin CL; Eaton CB; Buka SL; Kelsey KT
Epigenetics; 2016 Mar; 11(3):227-36. PubMed ID: 26891033
[TBL] [Abstract][Full Text] [Related]
19. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
[TBL] [Abstract][Full Text] [Related]
20. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking.
Shenker NS; Polidoro S; van Veldhoven K; Sacerdote C; Ricceri F; Birrell MA; Belvisi MG; Brown R; Vineis P; Flanagan JM
Hum Mol Genet; 2013 Mar; 22(5):843-51. PubMed ID: 23175441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]